TY - JOUR
T1 - Sleep disturbances are underappreciated in prostate cancer survivorship
AU - Gong, Fred
AU - Loeb, Stacy
AU - Siu, Katherine
AU - Myrie, Akya
AU - Orstad, Stephanie
AU - Kenfield, Stacey A.
AU - Morgans, Alicia
AU - Thakker, Sameer
AU - Robbins, Rebecca
AU - Carter, Patricia
AU - Jean-Louis, Girardin
AU - Nolasco, Tatiana Sanchez
AU - Byrne, Nataliya
AU - Gupta, Natasha
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2023/3
Y1 - 2023/3
N2 - Background: The prevalence of sleep disturbances among prostate cancer (PCa) survivors, and extent of urologist involvement in sleep care are not well-studied. Methods: PCa survivors (n = 167) and urologists (n = 145) were surveyed about sleep disturbances and survivorship care practices. Results: Most PCa survivors had sleep disturbances, including 50.9% with poor sleep quality, 18.0% with clinical/severe insomnia, and 36.5% at high-risk for sleep apnea. Few urologists routinely screened for sleep disturbances, as recommended in national cancer survivorship guidelines. Conclusions: Optimal PCa survivorship care should incorporate screening for sleep disturbances, addressing comorbid factors affecting sleep and referring to sleep medicine when appropriate.
AB - Background: The prevalence of sleep disturbances among prostate cancer (PCa) survivors, and extent of urologist involvement in sleep care are not well-studied. Methods: PCa survivors (n = 167) and urologists (n = 145) were surveyed about sleep disturbances and survivorship care practices. Results: Most PCa survivors had sleep disturbances, including 50.9% with poor sleep quality, 18.0% with clinical/severe insomnia, and 36.5% at high-risk for sleep apnea. Few urologists routinely screened for sleep disturbances, as recommended in national cancer survivorship guidelines. Conclusions: Optimal PCa survivorship care should incorporate screening for sleep disturbances, addressing comorbid factors affecting sleep and referring to sleep medicine when appropriate.
UR - http://www.scopus.com/inward/record.url?scp=85144485871&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85144485871&partnerID=8YFLogxK
U2 - 10.1038/s41391-022-00630-6
DO - 10.1038/s41391-022-00630-6
M3 - Article
C2 - 36543892
AN - SCOPUS:85144485871
SN - 1365-7852
VL - 26
SP - 210
EP - 212
JO - Prostate Cancer and Prostatic Diseases
JF - Prostate Cancer and Prostatic Diseases
IS - 1
ER -